Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backbone.
about
Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in AfricaHIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China.Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America NetworkNucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q34979072-3EA4C9B8-B1C3-4395-80C3-F99587F5FF7BQ35853812-5C823109-7090-4810-B2C6-A1654EBB5F8AQ36015636-B2332509-374D-47FE-A50C-64745702627FQ36134243-ADE04C2A-63A6-498F-87E3-4F99B6C55D32Q36462119-3C895F5B-9E06-481F-929E-ECD3102CD523Q38791126-BF0F5385-DE79-44EB-9BFB-358306B6D553Q40820470-01B9C885-D66C-4B41-960E-EABD65EDE391Q57180790-77102897-7A00-4EE8-9C6D-5A19E5DF743E
P2860
Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backbone.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Second-line protease inhibitor ...... fect of a nucleoside backbone.
@en
Second-line protease inhibitor ...... fect of a nucleoside backbone.
@nl
type
label
Second-line protease inhibitor ...... fect of a nucleoside backbone.
@en
Second-line protease inhibitor ...... fect of a nucleoside backbone.
@nl
prefLabel
Second-line protease inhibitor ...... fect of a nucleoside backbone.
@en
Second-line protease inhibitor ...... fect of a nucleoside backbone.
@nl
P2093
P356
P1433
P1476
Second-line protease inhibitor ...... fect of a nucleoside backbone.
@en
P2093
Andrew Phillips
Anton Pozniak
David Asboe
David Dunn
Erasmus Smit
Laura Waters
Loveleen Bansi
UK CHIC Study
UK HIV Drug Resustance Database
P304
P356
10.3851/IMP2329
P577
2013-01-01T00:00:00Z